Contact us:
Tel: +34 946 572 524

Research collaborations

CIC bioGUNE's Genome Analysis Platform collaborates with the following projects:

  • Systems Biology of Non Alcoholic Fatty Liver Diseases (In collaboration with Prof. Jose M. Mato and Dr. Maria Luz Martínez at CIC bioGUNE, Derio -Spain- & CIBERehd)
  • Linking cognitive disorders with Genetics Work-Package within the COEDUCA (Cognition and Education (CSD2008-0004/WP6 Consolider-Ingenio 2010 Project, In collaboration with Prof. Manuel Carreiras at BCBL, Donostia-San_Sebastian, Spain)
  • The role of Sall proteins and SUMO in development and steroidogenesis (PN/PIA12011-1, In collaboration with Dr. Rosa Barrio at CIC bioGUNE, Derio, Spain)
  • Functional and therapeutic implications in solid organ transplant (FIS/PI12702587, In collaboration with Dr. Carlos Larrea at Hospital Central de Asturias, Oviedo, Spain).
  • Evaluation of non-coding RNAs as non-invasive biomarkers of precancerous gastric lesions in patients infected with Helicobacter pylori (FIS/ PI12/01802, In collaboration with Dr. Mireia Miquel and Dr. Sergio Lario at Hospital Parc Tauli, Barcelona, Spain & CIBERehd)
  • Genetic characterization of treatment response in colorectal patients (In collaboration with Dr. Maria Luisa Maestro de las Casas at Hospital Clinico San Carlos, Madrid, Spain)
  • Epigenetic characterization of neural system development (In collaboration with Dr. Ashwin Woodhoo at CIC bioGUNE, Derio, Spain & CIBERehd)
  • Exosomes genetic content classification (In collaboration with Dr. Juan Manuel Falcon at CIC bioGUNE, Derio, Spain & CIBERehd)
  • Methodological approaches in prostate and breast cancer: from sample collection to the development of data mining tools (In collaboration with Dr. Arkaitz Carracedo at CIC bioGUNE, Derio, Spain)
  • Macrophage responses under disease conditions in murine models of inflammation (In collaboration with Dr. Juan Anguita at CIC bioGUNE, Derio, Spain)
  • Characterization of genetic profiles in response to corticosteroids treatment in ulcerative colitis (UC) patients (PI11/01691, In collaboration with Dr. Josep Manye and Dr. Eugeni Domènech at Unidad de enfermedad inflamatoria intestinal in Hospital Universitari "Germans Trias i Pujol" (HUGTP) & IGTP, Barcelona, Spain)
  • Secretome predictions and applications (In collaboration with Dr. Jose A. Oguiza at Universidad Publica de Navarra, Pamplona, Spain)
  • Searching for genetic alterations that cause NAFLD (In collaboration with Dr. Mercedes Vazquez-Chantada at AstraZeneca, Cambridge, UK; Azucena Castro at OWL metabolomics, Derio, Spain; and Prof. Richard Finnell at University of Texas in Austin, Texas, USA)
  • Metabolic characterization of metastatic prostate cancer for its application in precision medicine (In collaboration with Dr. Arkaitz Carracedo at CIC bioGUNE, Derio, Spain)